Karthikkumar Venkatachalam
Concepts (45)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depsides | 2 | 2016 | 2 | 0.950 |
Why?
|
| Cinnamates | 2 | 2016 | 6 | 0.950 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 117 | 0.910 |
Why?
|
| Receptors, Histamine H3 | 1 | 2021 | 1 | 0.760 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2021 | 1 | 0.760 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2021 | 1 | 0.760 |
Why?
|
| Dopamine Antagonists | 1 | 2021 | 2 | 0.760 |
Why?
|
| Histamine Antagonists | 1 | 2021 | 4 | 0.760 |
Why?
|
| Autistic Disorder | 1 | 2021 | 11 | 0.750 |
Why?
|
| Anticarcinogenic Agents | 1 | 2016 | 15 | 0.550 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 656 | 0.260 |
Why?
|
| Carcinogens | 3 | 2016 | 37 | 0.250 |
Why?
|
| Rats | 3 | 2016 | 1545 | 0.200 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 186 | 0.200 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2021 | 7 | 0.190 |
Why?
|
| Cerebellum | 1 | 2021 | 41 | 0.190 |
Why?
|
| Animals | 4 | 2021 | 9957 | 0.170 |
Why?
|
| Hippocampus | 1 | 2021 | 186 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 586 | 0.170 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 487 | 0.170 |
Why?
|
| Antioxidants | 2 | 2012 | 220 | 0.150 |
Why?
|
| Xenobiotics | 1 | 2016 | 4 | 0.140 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 47 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1476 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2016 | 79 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 98 | 0.130 |
Why?
|
| Feces | 1 | 2016 | 107 | 0.130 |
Why?
|
| Body Weight | 1 | 2016 | 246 | 0.130 |
Why?
|
| 1,2-Dimethylhydrazine | 2 | 2012 | 3 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2012 | 145 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2016 | 646 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 441 | 0.110 |
Why?
|
| Apoptosis | 1 | 2016 | 739 | 0.100 |
Why?
|
| Mice | 1 | 2021 | 4406 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2012 | 213 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 1393 | 0.080 |
Why?
|
| Flavonoids | 1 | 2008 | 30 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 32 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2012 | 624 | 0.070 |
Why?
|
| Male | 2 | 2012 | 12866 | 0.040 |
Why?
|
| beta-Glucosidase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Polysaccharide-Lyases | 1 | 2008 | 2 | 0.020 |
Why?
|
| Nitroreductases | 1 | 2008 | 4 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Colon | 1 | 2008 | 119 | 0.020 |
Why?
|